All In Biotech

Free tool

FAERS Monitor: Wainua (Autoinjector)

The FDA Adverse Event Reporting System collects reports from patients, clinicians and manufacturers. Counts are unverified reports, not rates: they rise with how widely a drug is used, how long it has been sold and media attention, a report can name several drugs, and a report does not show the drug caused the event.

Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations

Reports naming NDA 217388 or its brand name (Wainua (Autoinjector), Eplontersen Sodium). Reports on generic versions are filed under their own applications.

Reports

175

Serious

76

43% of reports

Hospitalization

21

Death reported

16

Any cause; not necessarily from the drug

Most reported reactions

MedDRA preferred terms.

  • death16
  • fatigue13
  • nausea13
  • neuropathy peripheral13
  • pain9
  • product dose omission issue7
  • vomiting7
  • diarrhoea6
  • hypoaesthesia6
  • pain in extremity6
  • paraesthesia6
  • vision blurred6
  • constipation5
  • drug ineffective5
  • pruritus5

Reports by year received

View as table
YearReports
202451
2025102
202622

Disproportionality screen

Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 21,053,984 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.

FDA's data service returned an error (500). The numbers below may be missing or incomplete.
ReactionReportsPRR95% CI lowerChi-squared
neuropathy peripheralSignal1316.49.7174
vision blurredSignal65.32.417
hypoaesthesiaSignal64.82.215
product dose omission issueSignal72.91.47
constipationSignal52.81.24
pain in extremity62.41.14
deathSignal162.21.410
fatigueSignal132.01.26
nausea132.01.26
vomiting71.80.92
pain91.80.92
pruritus51.60.71
diarrhoea61.10.50
drug ineffective50.50.23
paraesthesia60.00.0606,555

A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.